Progressive pulmonary infection is the dominant clinical feature of cystic
fibrosis (CF), but the molecular basis for this susceptibility remains inco
mpletely understood. To study this problem, we developed a model of chronic
pneumonia by repeated instillation of a clinical isolate of Burkholderia c
epacia (genomovar III, ET12 strain), an opportunistic gram-negative bacteri
um, from a case of CF into the lungs of Cftr mlunc(-/-) (Cftr(-/-)) and con
genic Cftr(+/+) controls. Nine days after the last instillation, the CF tra
nsmembrane regulator knockout mice showed persistence of viable bacteria wi
th chronic severe bronchopneumonia while wild-type mice remained healthy. T
he histopathological changes in the lungs of the susceptible Cftr(-/-) mice
were characterized by infiltration of a mixed inflammatory-cell population
into the peribronchiolar and perivascular spaces, Clara cell hyperplasia,
mucus hypersecretion in airways, and exudation into alveolar airspaces by a
mixed population of macrophages and neutrophils. An increased proportion o
f neutrophils was observed in bronchoalveolar lavage fluid from the Cftr(-/
-) mice, which, despite an increased bacterial load, demonstrated minimal e
vidence of activation. Alveolar macrophages from Cftr(-/-) mice also demons
trated suboptimal activation. These observations suggest that the pulmonary
host defenses are compromised in lungs from animals with CF, as manifested
by increased susceptibility to bacterial infection and lung injury. This m
urine model of chronic pneumonia thus reflects, in part, the situation in h
uman patients and may help elucidate the mechanisms leading to defective ho
st defense in CF.